Chilivis Grubman LLP
  • Home
  • Firm Overview
  • Attorneys
    • Scott R. Grubman
    • Lauren A. Warner
    • Jeremy T. Berry
    • Brittany M. Cambre
    • Joseph J. Siegelman
    • Hakim Hilliard
    • Sanjay Karnik
    • Serreen F. Meki
    • Brandi Z. Murrain
    • Rachel N. Lugay
    • Maiysha Rashad
  • Practice Areas
    • Healthcare
      • Government Investigations & Litigation
      • Payor Audits and Audit Appeals
      • HIPAA and Cybersecurity
      • Medical Board Investigations
      • Peer Review & Credentialing Disputes
      • Healthcare Regulatory Compliance
    • Civil and Business Litigation
      • Class Action Defense
    • Criminal Defense
      • White Collar Crime
      • Healthcare Fraud
      • Public Corruption
      • Internal Investigations
    • False Claims Act and Qui Tam Defense
    • Data Privacy & Cybersecurity
    • Internal Investigations
    • Government Affairs
      • Advocacy and Regulatory Affairs
      • Government Contracts
      • Government Litigation and Administrative Law
      • Advertising Compliance
      • Land Use & Zoning
      • Licensing and Permits
    • Campaign Finance and Election Law
    • Entertainment Law & Artist Management
      • Trademark, Copyright, and Brand Protection
  • Blog
  • News
  • Insights
  • Contact
Select Page

Pharmaceutical Manufacturer Agrees to Pay $3.6M to Resolve False Claims Act Investigation

May 11, 2025 | False Claims Act, Government Investigations, Health Care, Health Care Fraud

On May 9, 2025, the United States Department of Justice (DOJ) announced that pharmaceutical manufacturer Assertio Therapeutics had agreed to pay $3.6 million to resolve allegations that it violated the False Claims Act (FCA) by causing the submission of false claims...

Are the False Claims Act’s Qui Tam Provisions Constitutional? Another Court Weighs In

May 8, 2025 | False Claims Act, Fraud Investigations, Health Care, Health Care Fraud

Earlier this year, Chilivis Grubman founding partner Scott Grubman wrote an article for the Georgia State Bar Health Law Section’s Newsletter, wherein he discussed the continued fight over the constitutionality of the False Claims Act’s (FCA) qui tam (or...

DOJ Inks $202 Million False Claims Act Settlement Involving Gilead’s Physician Speaker Program

Apr 30, 2025 | False Claims Act, Health Care, Health Care Fraud

On April 29, 2025, the U.S. Department of Justice (United States Attorney’s Office, Southern District of New York) announced that pharmaceutical giant Gilead Sciences agreed to pay a whopping $202 Million to resolve a False Claims Act investigation.  At issue...

Department of Justice Files False Claims Act Lawsuit Against Wound Care Provider

Apr 14, 2025 | False Claims Act, Fraud Investigations, Government Investigations, Health Care, Health Care Fraud, Medicare and Medicaid

On April 4, 2025, the Department of Justice announced that it had filed a lawsuit under the federal False Claims Act against Vohra Wound Physicians Management and its founder, Dr. Ameet Vohra.  According to the DOJ, Dr. Vohra and his company allegedly submitted false...

Court Dismisses Lawsuit Against Wells Fargo Over Prescription Drug Costs: A Win for Employers in Healthcare Benefit Management

Apr 2, 2025 | Health Care, Health Care Fraud, Healthcare Transactions

A federal judge recently dismissed a lawsuit against Wells Fargo filed by a group of former employees who accused the bank of violating its fiduciary responsibilities by allowing its pharmacy benefit manager (PBM), Express Scripts, to overcharge for prescription...

The False Claims Act Meets the Eighth Amendment

Mar 30, 2025 | False Claims Act, Health Care, Health Care Fraud

The Eighth Amendment to the United States Constitution guarantees the “freedom from excessive fines.”  In 2018, the late Justice Ruth Bader Ginsberg held that this safeguard is “fundamental to our scheme of ordered liberty.”  Timbs v. Indiana. And yet, it is not...
« Older Entries

Recent Posts

  • DOJ Criminal Chief Issues Sweeping Memo Regarding White Collar Criminal Enforcement
  • Pharmaceutical Manufacturer Agrees to Pay $3.6M to Resolve False Claims Act Investigation
  • Are the False Claims Act’s Qui Tam Provisions Constitutional? Another Court Weighs In
  • Popular Restaurant Chain Pays $7.8 Million to Resolve Pandemic-Related False Claims Act Case
  • Robotics/AI Company Agrees to Seven-Figure False Claims Act Settlement

Categories

  • A.I. Law
  • Accessory Dwelling Units
  • Administrative Law
  • Anti-Counterfeit
  • Brand Protection
  • Business Litigation
  • Civil Healthcare Litigation
  • Civil Matters
  • Code Enforcement
  • Commercial Litigation
  • Commercial Payor Audits
  • Complex Criminal Litigation
  • Copyright Infringement
  • COVID-19 Related Law
  • Criminal Matters
  • Cyber Law
  • Data Breach
  • DMEPOS
  • DOJ
  • Drug Policy Law
  • Election Law
  • Employment Law
  • Environmental
  • False Claims Act
  • federal investigations
  • Federal Tax Investigations
  • FINRA
  • Firm Announcement
  • FOIS Compliance
  • Fraud Investigations
  • General
  • Government Affairs
  • Government Contract
  • Government Investigations
  • Government Litigation
  • Health Care
  • Health Care Fraud
  • Healthcare Transactions
  • HIPAA
  • Housing Development Law
  • Land Use Law
  • Land Zoning Law
  • Liquor Law
  • Medicare and Medicaid
  • Non-Profit Organizations
  • ommercial payor audits
  • Open Records Act
  • Overpayment Appeals
  • PPP Investigations
  • Public Corruption
  • Restrictive Covenants
  • SEC Investigations
  • Special Use Permit Filing
  • State Bar of Georgia Investigations
  • Strategic Land Use
  • Tax Fraud
  • toxic tort
  • Trademark Enforcement
  • Trademark Protection
  • Tree Ordinance
  • Uncategorized
  • Variances
  • White Collar Crime
  • Zoning and Land Use
Built by The Montgomery Group